iBio, Inc.
IBIO · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Stoner Elizabeth: Form 4
Insider disclosure · Filed · Report period 14 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001420720 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- IBIO on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 600 Madison Avenue, Suite 1601, New York, NY, 10022-1737
- Incorporated in
- DE
- Fiscal year end
- 30 June
- Former names on EDGAR
- iBioPharma, Inc. (to 14 Aug 2009), InB:Biotechnologies, Inc. (to 17 Jul 2008)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields